Find a Pharmacy
Vertice Login
Menu
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays  ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

The Advocacy & 
Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.
Subscribe

Department of Justice Reaches $21.5 Million Settlement Over Inflated AWP for Compound Ingredients

According to the DOJ, Medisca Inc. purchased resveratrol at $0.37 a gram, sold it for under $2.00 a gram, but reported an AWP of $777 per gram.
Read More →
November 11, 2024

Psychedelic Study Shows Improvements in Anxiety without Hallucinations

When injected into the hippocampus, the compound DOI reduced anxiety in mice without causing hallucinations.
Read More →
November 4, 2024

Texas Seeks Input On 2025 Medical Quality Review Audit Plan

Comments will be accepted until 5:00 PM PST on November 22, 2024, and the Medical Advisor may adjust the plan based on feedback received.
Read More →
November 4, 2024

Pennsylvania Publishes Prescription Drug Trends Report

This report reviews drug payments between 2012 and 2022, reviewing usage and cost, generics, opioids, and topicals.
Read More →
November 4, 2024

Nevada to Hold Four Workers’ Comp Training Webinars

The webinars will cover basic orientation, the C-4 process and using the coverage verification system, the D-35 form, and medical billing.
Read More →
November 4, 2024

Mississippi Requests Stakeholder Input for 2025 Fee Schedule

No deadline for feedback has been given, but the Commission will consider feedback for fee schedule changes for 2025.
Read More →
November 4, 2024

Arizona Offers Medical Resource Training Opportunities for Workers’ Comp Stakeholders

A four-part series of 30-minute training webinars are available for adjusters, payers, healthcare providers, and TPAs.
Read More →
November 4, 2024

NCCI Reports on Adverse Weather and Workers’ Comp Claims

Using data from 35 states from 2001-2022, the report noted up to 10% higher claim frequency in both significantly hotter and colder temperatures.
Read More →
October 28, 2024

NCCI Reports on Medical Inflation

After starting the year with 3.5% growth, the inflation moderated to around 2.5% in Q3, consistent with trends from 2022-2023.
Read More →
October 28, 2024
1 … 38 39 40 41 42 … 46

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.
regulatory recap newsletter image
hello world!

 Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

JAMA Compares Effectiveness of Treatment Pathways for Opioid Use Disorder

A study of 41,000 adults finds that only treatment with buprenorphine or methadone reduced risk of overdose.
Read More

Embracing Telehealth in Reaction to COVID-19

Several state workers’ comp programs are relaxing telehealth rules to promote social distancing.
Read More

Sandy Shtab Featured in IAIABC Member Spotlight

Healthesystems’ AVP of Advocacy & Compliance discusses industry challenges, special initiatives, and more in a video spotlight.
Read More

FDA Approves Diazepam Nasal Spray and Fast Tracks New Drug for Spinal Cord Injury

A new seizure drug has been approved, and a nerve growth drug advances in clinical trials.
Read More

4 Regulatory Trends to Watch Out for in 2020

What will 2020 hold for marijuana acceptance, employee misclassification, formularies, and AI?
Read More

WCIRB Publishes Physical Medicine Report

An analysis of 1.5 million claims found early physical therapy lowers odds of opioid use by 14%.
Read More
1 … 38 39 40 41 42 … 49
Back to Top
lockmap-markermagnifiercrossmenuarrow-rightcross-circle